PFE · News · 20261106N
Domestic Manufacturing Investment
PFIZER INC · 2026-11-06 · Importance 46 · Surprise 42 · In source text
Third-party reports say Pfizer plans to invest $650 million over five years in a 220,000-square-foot manufacturing technology center at its Groton, Connecticut, R&D campus. The U.S. facility is expected to produce clinical active pharmaceutical ingredients and drug products for Pfizer’s global clinical trials. Operations are expected to begin in mid-2031, and a separate report describes the project as a long-term expansion of R&D and supply-chain capabilities.
Key facts
- Pfizer plans to invest $650 million over five years to build a 220,000-square-foot manufacturing technology center at its Groton, Connecticut R&D campus; the facility will produce clinical active pharmaceutical ingredients and drug products for global clinical trials, with operations expected to begin in mid-2031. source
- Pfizer describes its planned US$650 million Connecticut manufacturing technology center as a long-term expansion of its R&D and supply chain capabilities tied to future portfolio needs. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | committed | -0.3% | Pfizer plans to invest $650 million over five years to build a 220,000-square-foot manufacturing technology center at its Groton,… |
| assets | positive | committed | +0.3% | Pfizer plans to invest $650 million over five years to build a 220,000-square-foot manufacturing technology center at its Groton,… |